SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddy's recalls around 70,000 vials of Zoledronic acid injection from US

04 Oct 2018 Evaluate

Dr. Reddy’s Laboratories has initiated recall of around 70,000 vials of Zoledronic acid injection manufactured by Gland Pharma from the US market. The company is recalling the vials on account of ‘Out-of-specification result observed for related substance: unknown impurity’.

The company is recalling 59,468 vials of Zoledronic acid injection, 5mg/100 mL (0.05 mg/mL) 100ml vial and 10,530 vials of Zoledronic acid injection, 5 mg/100 mL (0.05 mg/mL) one 100ml single-dose bottle.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1279.70 -13.55 (-1.05%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×